A. Delbaere et al., PRORENIN AND ACTIVE RENIN CONCENTRATIONS IN PLASMA AND ASCITES DURINGSEVERE OVARIAN HYPERSTIMULATION SYNDROME, Human reproduction, 12(2), 1997, pp. 236-240
The pathophysiology of ovarian hyperstimulation syndrome (OHSS) remain
s unclear. Several lines of evidence indicate that OHSS is associated
with a stimulation of the renin-angiotensin system (RAS), but its func
tional significance as well as its role in the pathogenesis of the syn
drome are not yet determined. OHSS is associated with high plasma and
ascitic concentrations of total renin, renin activity (RA) and angiote
nsin II (Ang II). Their ovarian or renal origin is, however, still a m
atter of debate. To clarify these issues further, total renin, active
renin, prorenin, RA and aldosterone were measured in plasma and ascite
s of nine patients who developed severe OHSS after in-vitro fertilizat
ion. Blood and ascites were sampled simultaneously during therapeutic
paracentesis. Total renin and prorenin concentrations were significant
ly higher in the ascites (mean concentration +/- SE respectively of 59
20 +/- 1430 mIU/1 and 5250 +/- 1350 mIU/1) than in the plasma (respect
ively 3060 +/- 740 mIU/1 and 2000 +/- 460 mIU/1) (P = 0.020 and 0.017
respectively). Conversely, active renin and RA concentrations tended t
o be lower, although not statistically significantly so in the ascites
(respectively 670 +/- 190 mIU/1 and 47 +/- 11 ng Ang I/m/h) than in t
he plasma (respectively, 1060 +/- 370 mIU/1 and 75 +/- 21 ng Ang I/ml/
h). Aldosterone concentrations were significantly higher in the serum
(2609 +/- 374 pg/ml) than in the ascites (2025 +/- 347 pg/ml) (P = 0.0
15). The concentration gradient between plasma and ascites for total r
enin and prorenin supports the hypothesis of their ovarian origin in a
scites and, to a large extent, in plasma, while it is likely that the
high plasma active renin and RA concentrations reflect a peripheral ac
tivation of the RAS. In conclusion, the present findings are consisten
t with a marked stimulation of both ovarian and renal RAS during OHSS.